Companies
ICON plc HEOR
- Country
- Ireland
- Ticker
- NASDAQ:ICLR
EU
Coverage
| EU | US | |
|---|---|---|
| regulatory-legal | ✓ | ✓ |
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Headcount | 40,100 employees (2025-12-31) | biospace.com |
| Revenue | $8,251.3 million (2025-12-31) | biospace.com |
| Production site | Central Laboratory facilities in Farmingdale (USA), Dublin (Ireland), Singapore, and Beijing (China) | icon.widen.net · iconplc.com |
| Certification | CAP (College of American Pathologists), CLIA (Clinical Laboratory Improvement Amendments), NGSP, ISO 15189, and Shanghai Centre of Clinical Laboratory (SCCL) certifications/accreditations | icon.widen.net · iconplc.com |
| Regulatory approval | Operates under various global regulatory requirements; maintains records for inspection by regulatory authorities and clients during audits | investor.iconplc.com |
| Capacity | Operates GMP-compliant manufacturing sites for early clinical manufacturing, as well as specialized clinical research units with integrated laboratory and pharmacy infrastructure | iconplc.com |
Independent sources: biospace.com · investor.iconplc.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Health economics and outcomes research (HEOR) services | regulatory-legal | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.